| pubmed-article:15470580 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15470580 | lifeskim:mentions | umls-concept:C0086409 | lld:lifeskim |
| pubmed-article:15470580 | lifeskim:mentions | umls-concept:C0681867 | lld:lifeskim |
| pubmed-article:15470580 | lifeskim:mentions | umls-concept:C0759933 | lld:lifeskim |
| pubmed-article:15470580 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:15470580 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:15470580 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:15470580 | lifeskim:mentions | umls-concept:C1880177 | lld:lifeskim |
| pubmed-article:15470580 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:15470580 | pubmed:dateCreated | 2004-10-7 | lld:pubmed |
| pubmed-article:15470580 | pubmed:abstractText | Eletriptan is a recently marketed second-generation triptan with a potent agonist activity on 5-HT1B/ 1D receptors. Our aim has been to analyze the specific results from the Spanish participation in phase IIIa and IIIb clinical trials vs placebo and compare them with the results obtained in the global clinical development of eletriptan. | lld:pubmed |
| pubmed-article:15470580 | pubmed:language | spa | lld:pubmed |
| pubmed-article:15470580 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15470580 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15470580 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:15470580 | pubmed:issn | 0213-4853 | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:LiañoHH | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:NavarroAA | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:PalaciosGG | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:PascualJJ | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:JiménezDD | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:MateosVV | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:Díez-TejedorE... | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:LeiraRR | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:MadrigalMM | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:LainezJ MJM | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:EzpeletaDD | lld:pubmed |
| pubmed-article:15470580 | pubmed:author | pubmed-author:Grupo de... | lld:pubmed |
| pubmed-article:15470580 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15470580 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:15470580 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15470580 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15470580 | pubmed:pagination | 414-9 | lld:pubmed |
| pubmed-article:15470580 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:meshHeading | pubmed-meshheading:15470580... | lld:pubmed |
| pubmed-article:15470580 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15470580 | pubmed:articleTitle | [Spanish contribution to the clinical development of eletriptan: an analysis of controlled studies]. | lld:pubmed |
| pubmed-article:15470580 | pubmed:affiliation | Servicio de Neurología, Hospital Universitario Marqués de Valdecilla, Santander. juliopascual@telefonica.net | lld:pubmed |
| pubmed-article:15470580 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15470580 | pubmed:publicationType | English Abstract | lld:pubmed |
